Solid Biosciences Inc.

NASDAQ:SLDB

5.66 (USD) • At close November 4, 2024
Bedrijfsnaam Solid Biosciences Inc.
Symbool SLDB
Munteenheid USD
Prijs 5.66
Beurswaarde 218,448,832
Dividendpercentage 0%
52-weken bereik 2 - 15.05
Industrie Biotechnology
Sector Healthcare
CEO Mr. Alexander G. Cumbo
Website https://www.solidbio.com

An error occurred while fetching data.

Over Solid Biosciences Inc.

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate

Vergelijkbare Aandelen

ReWalk Robotics Ltd. logo

ReWalk Robotics Ltd.

RWLK

1.05 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.634 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

40.63 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

3.06 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)